by qfrsolutions | Aug 22, 2017 | News
Source: FierceBiotech Encore Dermatology, formed two years ago as a vehicle for three ex-Valeant products, has picked up a late-stage pipeline drug via a deal with India’s Dr. Reddy’s Laboratories. The Malvern, Pennsylvania, company says it has licensed a...
by qfrsolutions | Aug 17, 2017 | News
Source: PR Newswire Prollenium Medical Technologies Inc., a leading medical device manufacturer, announced today its United States (U.S.) Food and Drug Administration (FDA) approval for its cross-linked hyaluronic acid dermal filler. Ario Khoshbin, Founder and CEO,...
by qfrsolutions | Aug 14, 2017 | News
Source: Nearly one year ago, as the pharma industry was beset by pricing scrutiny, Allergan CEO Brent Saunders pledged to keep his company’s hikes under 10%. Since then, that pricing rule has spread—even among companies that haven’t publicly promised...
by qfrsolutions | Jul 17, 2017 | News
Source: Globe Newswire Fortress Biotech, Inc. (FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced that Columbia University...
by qfrsolutions | Jun 8, 2017 | News
Source: PR Newswire Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that Allergan’s wholly-owned subsidiary, Allergan Sales LLC agreed to acquire Keller Medical, Inc., a privately held medical device company and developer of...
by qfrsolutions | May 22, 2017 | News
Source: Business Wire Nestlé has appointed Stuart Raetzman as CEO of Nestlé Skin Health, effective immediately. “I am very pleased that Stuart will be leading Nestlé Skin Health as CEO. Nestlé’s purpose is to enhance quality of...
